Found: 49
Select item for more details and to access through your institution.
Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7651, doi. 10.1007/s00432-023-04691-5
- By:
- Publication type:
- Article
HER2 testing in gastric cancer: results of a German expert meeting.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 5, p. 835, doi. 10.1007/s00432-017-2374-x
- By:
- Publication type:
- Article
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma--a phase II trial of the AIO study group (AIO STO 0321).
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1272175
- By:
- Publication type:
- Article
European-Australasian consensus on the management of advanced gastric and gastro-oesophageal junction cancer: current practice and new directions.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221118874
- By:
- Publication type:
- Article
Prediction of Response and Prognosis by a Score Including Only Pretherapeutic Parameters in 410 Neoadjuvant Treated Gastric Cancer Patients.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 7, p. 2119, doi. 10.1245/s10434-012-2254-1
- By:
- Publication type:
- Article
Prognostic Significance of Free Peritoneal Tumor Cells in the Peritoneal Cavity Before and After Neoadjuvant Chemotherapy in Patients with Gastric Carcinoma Undergoing Potentially Curative Resection.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 10, p. 2733, doi. 10.1245/s10434-010-1090-4
- By:
- Publication type:
- Article
RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immunotherapy: New Options in Gastrointestinal Cancers?
- Published in:
- Visceral Medicine, 2019, v. 35, n. 1, p. 47, doi. 10.1159/000497293
- By:
- Publication type:
- Article
Adenokarzinome des Magens und des gastroösophagealen Übergangs: Kooperationsprojekte bieten neue Chancen.
- Published in:
- Kompass Onkologie, 2020, v. 7, n. 2, p. 71, doi. 10.1159/000507949
- By:
- Publication type:
- Article
Erstellung molekularer Tumorprofile durch Liquid Biopsy - Zukunft für das kolorektale Karzinom?
- Published in:
- Kompass Onkologie, 2019, v. 6, n. 2, p. 90, doi. 10.1159/000499617
- By:
- Publication type:
- Article
Metastasiertes Magenkarzinom - längeres Überleben durch Resektion?
- Published in:
- Kompass Onkologie, 2018, v. 5, n. 1, p. 22, doi. 10.1159/000486179
- By:
- Publication type:
- Article
Überlebensvorteil durch Primärtumorresektion bei metastasiertem Kolorektalkarzinom?
- Published in:
- Kompass Onkologie, 2017, v. 4, n. 1, p. 34, doi. 10.1159/000455319
- By:
- Publication type:
- Article
Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0132386
- By:
- Publication type:
- Article
Optimal use of granulocyte colony-stimulating factor prophylaxis to improve survival in cancer patients receiving treatment: An expert view.
- Published in:
- 2024
- By:
- Publication type:
- Proceeding
Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023.
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 5, p. 224, doi. 10.1159/000538324
- By:
- Publication type:
- Article
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023.
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 5, p. 233, doi. 10.1159/000537935
- By:
- Publication type:
- Article
Colorectal Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2023.
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 5, p. 229, doi. 10.1159/000538110
- By:
- Publication type:
- Article
Oncology in Europe.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 345, doi. 10.1159/000529681
- By:
- Publication type:
- Article
Programmed Cell Death Protein 1 Blockade Elicits Ongoing Remission in 2 Cases of Refractory Epstein-Barr Virus-Associated Metastatic Gastric Carcinoma.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 6, p. 375, doi. 10.1159/000523754
- By:
- Publication type:
- Article
PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation.
- Published in:
- Oncology Research & Treatment, 2022, v. 45, n. 4, p. 222, doi. 10.1159/000521332
- By:
- Publication type:
- Article
Oncology Research and Treatment 2020: Past, Present, and Future.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Influence of Taxanes on Treatment Sequence in Gastric Cancer.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 1/2, p. 42, doi. 10.1159/000503428
- By:
- Publication type:
- Article
Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 5, p. 266, doi. 10.1159/000488120
- By:
- Publication type:
- Article
HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1336, doi. 10.3390/cancers16071336
- By:
- Publication type:
- Article
HER-2-Positive Tumors: A Continuously Evolving Field in Cancer Research.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3631, doi. 10.3390/cancers14153631
- By:
- Publication type:
- Article
High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients.
- Published in:
- Sarcoma, 2018, p. 1, doi. 10.1155/2018/1632978
- By:
- Publication type:
- Article
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11004-z
- By:
- Publication type:
- Article
Evaluation of EGFR inhibitor‐mediated acneiform skin toxicity within the double‐blind randomized EVITA trial: A thorough gender‐specific analysis using the WoMo score.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 9, p. 4169, doi. 10.1002/cam4.2132
- By:
- Publication type:
- Article
Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first‐line therapy.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 12, p. 2142, doi. 10.1002/ijc.34894
- By:
- Publication type:
- Article
Ramucirumab beyond progression plus TAS‐102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab‐based therapy.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 10, p. 1726, doi. 10.1002/ijc.34652
- By:
- Publication type:
- Article
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACO.
- Published in:
- BMC Cancer, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12885-021-08872-8
- By:
- Publication type:
- Article
Moderne Konzepte der Systemtherapie zur adjuvanten und palliativen Behandlung des lokal fortgeschrittenen oder metastasierten Ösophaguskarzinoms.
- Published in:
- Der Chirurg, 2021, v. 92, n. 12, p. 1085, doi. 10.1007/s00104-021-01476-9
- By:
- Publication type:
- Article
New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 62, doi. 10.1159/000443984
- By:
- Publication type:
- Article
Ramucirumab plus FOLFIRI or irinotecan as second-line treatment for patients with gastroesophageal adenocarcinoma: a review and meta-analysis of an emerging option.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1419338
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluromisonidazole PET Imaging as a Biomarker for the Response to 5,6-Dimethylxanthenone-4-Acetic Acid in Colorectal Xenograft Tumors.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 3, p. 437, doi. 10.2967/jnumed.110.081372
- By:
- Publication type:
- Article
Phenotyping of Tumor Biology in Patients by Multimodality Multiparametric Imaging: Relationship of Microcirculation, α<sub>v</sub>β<sub>3</sub> Expression, and Glucose Metabolism.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 11, p. 1691, doi. 10.2967/jnumed.110.077719
- By:
- Publication type:
- Article
Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen (RADPAC)
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 9, p. 2493, doi. 10.1002/ijc.33025
- By:
- Publication type:
- Article
Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153943
- By:
- Publication type:
- Article
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 1, p. 6, doi. 10.1007/s10120-023-01424-y
- By:
- Publication type:
- Article
Optimal chemotherapy for advanced gastric cancer: is there a global consensus?
- Published in:
- Gastric Cancer, 2014, v. 17, n. 2, p. 213, doi. 10.1007/s10120-013-0297-z
- By:
- Publication type:
- Article
Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas.
- Published in:
- Journal of Pathology: Clinical Research, 2020, v. 6, n. 4, p. 263, doi. 10.1002/cjp2.169
- By:
- Publication type:
- Article
Treatment of Patients with Advanced Gastroesophageal Adenocarcinoma: Does Age Matter?
- Published in:
- Drugs & Aging, 2019, v. 36, n. 5, p. 403, doi. 10.1007/s40266-019-00638-z
- By:
- Publication type:
- Article
Clinical management patterns of advanced and metastatic gastro‐oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom.
- Published in:
- European Journal of Cancer Care, 2020, v. 29, n. 2, p. 1, doi. 10.1111/ecc.13213
- By:
- Publication type:
- Article
Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Comparison of Integrin α<sub>v</sub>β<sub>3</sub> Expression and Glucose Metabolism in Primary and Metastatic Lesions in Cancer Patients: A PET Study Using <sup>18</sup>F-Galacto-RGD and <sup>18</sup>F-FDG.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 1, p. 22, doi. 10.2967/jnumed.107.045864
- By:
- Publication type:
- Article
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): The Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 266, doi. 10.1186/1471-2407-11-266
- By:
- Publication type:
- Article